Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sodium Correction Practice and Clinical Outcomes in Profound Hyponatremia.
1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls.
Responsiveness of selected outcome measures of participation restriction and quality of life in patients with multiple sclerosis.
Tablet-based screening improves continence management in multiple sclerosis.
The Impact of Methylprednisolone Pulses during Relapses of Multiple Sclerosis on the Kinetics of Anti-Interferon-Beta Antibodies.
Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients.
Body Mass Index in Multiple Sclerosis: Associations with CSF Neurotransmitter Metabolite Levels.
[Clinical and electrophysiological and molecular genetic characteristics of the course of relapsing-remitting multiple sclerosis.]
Comparison of ActiGraph activity monitors in persons with multiple sclerosis and controls.
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
Multiple sclerosis: Fatigue-a warning sign for multiple sclerosis?
[Teriflunomide for treatment of multiple sclerosis.]
Clinical outcome measures in multiple sclerosis.
Us Rrms Patient Preferences for Multiple Sclerosis Treatments: An Online Survey.
Herpes Simplex Virus-related Transverse Myelitis and Polyneuritis.
RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
Impaired retinal microcirculation in multiple sclerosis.
Effects of High Glucose on Cell Viability and Differentiation in Primary Cultured Schwann Cells: Potential Role of ERK Signaling Pathway.
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations.
Cardiac stunning as first manifestation of multiple sclerosis: A case report reminding us not to overlook cardiovascular autonomic dysfunction in multiple sclerosis.
Multiple sclerosis: Fingolimod failure in progressive MS INFORMS future trials.
Editorial: Glial Cells: Managers of Neuro-Immunity.
Impaired Carotid Baroreflex Control of Arterial Blood Pressure in Multiple Sclerosis.
Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood.
The Role of fMRI to Assess Plasticity of the Motor System in MS.
Pages
« first
‹ previous
…
664
665
666
667
668
669
670
671
672
…
next ›
last »